OppenheimerFunds Inc. cut its holdings in Nutrisystem (NASDAQ:NTRI) by 97.6% during the fourth quarter, Holdings Channel reports. The institutional investor owned 9,171 shares of the company’s stock after selling 381,027 shares during the period. OppenheimerFunds Inc.’s holdings in Nutrisystem were worth $483,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the company. Atlantic Trust Group LLC purchased a new position in shares of Nutrisystem during the 3rd quarter worth about $1,151,000. Capital Fund Management S.A. boosted its stake in shares of Nutrisystem by 225.1% during the 4th quarter. Capital Fund Management S.A. now owns 102,400 shares of the company’s stock worth $5,386,000 after purchasing an additional 70,900 shares during the period. U S Global Investors Inc. purchased a new position in shares of Nutrisystem during the 3rd quarter worth about $1,023,000. Copper Rock Capital Partners LLC boosted its stake in shares of Nutrisystem by 3.6% during the 4th quarter. Copper Rock Capital Partners LLC now owns 493,793 shares of the company’s stock worth $26,048,000 after purchasing an additional 17,111 shares during the period. Finally, California Public Employees Retirement System boosted its stake in shares of Nutrisystem by 65.8% during the 3rd quarter. California Public Employees Retirement System now owns 21,223 shares of the company’s stock worth $1,186,000 after purchasing an additional 8,423 shares during the period.

In other news, CEO Dawn M. Zier sold 30,006 shares of the company’s stock in a transaction that occurred on Friday, January 12th. The shares were sold at an average price of $52.36, for a total value of $1,571,114.16. Following the completion of the sale, the chief executive officer now owns 224,659 shares of the company’s stock, valued at approximately $11,763,145.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Keira Krausz sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, January 11th. The stock was sold at an average price of $50.96, for a total transaction of $254,800.00. Following the completion of the sale, the insider now directly owns 75,463 shares of the company’s stock, valued at approximately $3,845,594.48. The disclosure for this sale can be found here. Insiders sold a total of 75,831 shares of company stock valued at $3,566,319 in the last ninety days. Corporate insiders own 2.40% of the company’s stock.

A number of equities analysts recently commented on NTRI shares. BidaskClub cut shares of Nutrisystem from a “hold” rating to a “sell” rating in a research note on Tuesday, January 23rd. Zacks Investment Research cut shares of Nutrisystem from a “buy” rating to a “hold” rating in a research report on Tuesday, January 2nd. DA Davidson reissued a “buy” rating and issued a $80.00 price objective on shares of Nutrisystem in a research report on Friday, December 22nd. Craig Hallum lowered their price objective on shares of Nutrisystem from $80.00 to $50.00 and set a “buy” rating for the company in a research report on Tuesday, February 27th. Finally, B. Riley set a $52.00 price objective on shares of Nutrisystem and gave the company a “buy” rating in a research report on Thursday, February 22nd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the stock. Nutrisystem currently has an average rating of “Hold” and an average target price of $57.00.

Shares of Nutrisystem (NASDAQ NTRI) opened at $28.00 on Friday. The stock has a market cap of $874.52, a PE ratio of 14.77, a price-to-earnings-growth ratio of 0.85 and a beta of 1.03. Nutrisystem has a 52-week low of $27.95 and a 52-week high of $67.95.

Nutrisystem (NASDAQ:NTRI) last released its quarterly earnings data on Monday, February 26th. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.02. The company had revenue of $131.20 million during the quarter, compared to analysts’ expectations of $128.75 million. Nutrisystem had a net margin of 8.30% and a return on equity of 48.69%. The firm’s quarterly revenue was up 20.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.29 EPS. analysts anticipate that Nutrisystem will post 2.05 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 19th. Shareholders of record on Thursday, March 8th were given a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 3.57%. This is a boost from Nutrisystem’s previous quarterly dividend of $0.18. The ex-dividend date was Wednesday, March 7th. Nutrisystem’s payout ratio is 52.63%.

WARNING: This article was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.watchlistnews.com/oppenheimerfunds-inc-trims-stake-in-nutrisystem-ntri/1960229.html.

About Nutrisystem

Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.

Want to see what other hedge funds are holding NTRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrisystem (NASDAQ:NTRI).

Institutional Ownership by Quarter for Nutrisystem (NASDAQ:NTRI)

Receive News & Ratings for Nutrisystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrisystem and related companies with MarketBeat.com's FREE daily email newsletter.